John Furey
2017
In 2017, John Furey earned a total compensation of $737.3K as Chief Operating Officer at Spark Therapeutics, a 87% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $248,400 |
|---|---|
| Salary | $450,000 |
| Other | $38,942 |
| Total | $737,342 |
Furey received $450K in salary, accounting for 61% of the total pay in 2017.
Furey also received $248.4K in non-equity incentive plan and $38.9K in other compensation.
Rankings
In 2017, John Furey's compensation ranked 10,374th out of 14,666 executives tracked by ExecPay. In other words, Furey earned more than 29.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,374 out of 14,666 | 29th |
Division Manufacturing | 4,021 out of 5,768 | 30th |
Major group Chemicals And Allied Products | 1,421 out of 2,074 | 32nd |
Industry group Drugs | 1,156 out of 1,730 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 209 out of 316 | 34th |
Source: SEC filing on July 22, 2019.
Furey's colleagues
We found five more compensation records of executives who worked with John Furey at Spark Therapeutics in 2017.
2017
Jeffrey Marrazzo
Spark Therapeutics
Chief Executive Officer
2017
Katherine High
Spark Therapeutics
President and Head of Research and Development
2017
Daniel Faga
Spark Therapeutics
Chief Business Officer
2017
Stephen Webster
Spark Therapeutics
Chief Financial Officer
2017
Joseph Barge
Spark Therapeutics